However, in a cohort of persons doing well on highly active antiretroviral therapy (HAART) with a sufficiently improved mean CD4 count, there is little variability in CD4 count of the group and therefore a difference in dyslipidaemia cannot be attributed to differences in CD4 counts. Here, CD4 is linked to inherited lipid metabolism disorder.